Lumb Richard, Bastion Ivan, Carter Robyn, Jelfs Peter, Keehner Terillee, Sievers Aina
Microbiology and Infectious Diseases Directorate, SA Pathology, Adelaide, South Australia.
Commun Dis Intell Q Rep. 2011 Jun;35(2):154-61.
There were 886 and 1,062 bacteriologically-confirmed cases of tuberculosis (TB) in 2008 and 2009, representing an annual rate of 4.1 and 4.9 cases per 100,000 population respectively. Over the 2 years, a total of 23 children aged under 10 years (male n = 13, female n = 10) had bacteriologically confirmed tuberculosis, including 3 children with TB meningitis. Results of in vitro drug susceptibility testing were available for 885 of 886 and 1,060 of 1,062 isolates for isoniazid (INH), rifampicin (RIF), ethambutol (EMB), and pyrazinamide (PYZ) in 2008 and 2009 respectively. In 2008, a total of 94 (10.7%) isolates of Mycobacterium tuberculosis complex were resistant to at least one of the anti-tuberculosis agents. Any resistance to INH was noted for 76 (8.7%), 23 (2.6%) for RIF, 10 (1.1%) for EMB and 9 (1.0%) for PYZ. Resistance to at least INH and RIF (defined as multidrug-resistant TB (MDR-TB) was detected in 21 (2.4%) isolates. None of the 21 MDR-TB isolates had resistance to either ofloxacin or the injectable agents. In 2009, a total of 168 (15.9%) were resistant to at least one of the anti-TB agents. Any resistance to INH was noted for 150 (14.2%) isolates, 37 (3.5%) for RIF, 5 (0.5%) for EMB and 13 (1.2%) for PYZ. A total of 31 (2.9%) isolates were MDR-TB. In 2009, there were 2 cases of quinolone resistance in MDR-TB from persons born overseas. Mono-resistance to INH was the most commonly detected resistance with 33 and 80 isolates in 2008 and 2009, respectively. Mono-resistance to RIF was infrequently encountered with 2 and 5 isolates in 2008 and 2009 respectively. There were six and 11 MDR-TB patients from the Papua New Guinea (PNG) - Torres Strait Islands (TSI) cross-border region in 2008 and 2009 respectively. The PNG-TSI zone now contributes a substantial proportion of MDR-TB cases to the database. In addition, there were 24 isolates of Mycobacterium bovis bacille Calmette Guérin (BCG), 15 were cultured from males (4 aged < or = 5 years) and from 9 females (5 aged < or = 5 years). The predominant site of isolation was from vaccination abscess. Eight males (range: 57-87 years) had M. bovis BCG isolated from urine or blood culture.
2008年和2009年分别有886例和1062例经细菌学确诊的结核病病例,发病率分别为每10万人口4.1例和4.9例。在这两年中,共有23名10岁以下儿童(男13名,女10名)经细菌学确诊患有结核病,其中包括3例结核性脑膜炎患儿。2008年和2009年,分别有886株和1062株结核分枝杆菌分离株进行了异烟肼(INH)、利福平(RIF)、乙胺丁醇(EMB)和吡嗪酰胺(PYZ)的体外药敏试验,结果分别有885株和1060株可用。2008年,共有94株(10.7%)结核分枝杆菌复合群分离株对至少一种抗结核药物耐药。对INH耐药的有76株(8.7%),对RIF耐药的有23株(2.6%),对EMB耐药的有10株(1.1%),对PYZ耐药的有9株(1.0%)。检测到21株(2.4%)分离株对至少INH和RIF耐药(定义为耐多药结核病[MDR-TB])。21株MDR-TB分离株对氧氟沙星或注射用药物均无耐药。2009年,共有168株(15.9%)对至少一种抗结核药物耐药。对INH耐药的有150株(14.2%),对RIF耐药的有37株(3.5%),对EMB耐药的有5株(0.5%),对PYZ耐药的有13株(1.2%)。共有31株(2.9%)分离株为MDR-TB。2009年,有2例海外出生的MDR-TB患者对喹诺酮耐药。对INH的单耐药是最常见的耐药类型,2008年和2009年分别有33株和80株。对RIF的单耐药很少见,2008年和2009年分别有2株和5株。2008年和2009年分别有6例和11例来自巴布亚新几内亚(PNG)-托雷斯海峡群岛(TSI)跨境地区 的MDR-TB患者。PNG-TSI地区现在在数据库中占了相当比例的MDR-TB病例。此外,有24株卡介苗(BCG),其中15株从男性中培养(4例年龄≤5岁),9株从女性中培养(5例年龄≤5岁)。主要分离部位是接种部位脓肿。8名男性(年龄范围:57 - 87岁)的尿液或血培养中分离出卡介苗。